Listed

Orthopediatrics Corp

KIDSNasdaqCIK 1425450HealthcareFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$70.5mRevenue, Q2 FY2026, three months to 2026-06-30$70.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001425450-26-000070.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 5, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$70.5mRevenue, Q2 FY2026, three months to 2026-06-30$70.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001425450-26-000070.Report this figure+15.4% on a year earlier
  • Gross margin74.3%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $52.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-05, accession 0001425450-26-000070.Revenue: $70.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001425450-26-000070.Report this figure+2.2 pts on a year earlier
  • Operating margin−5.8%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$4.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001425450-26-000070.Revenue: $70.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001425450-26-000070.Report this figure+11.7 pts on a year earlier
  • Net margin−10.2%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$7.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001425450-26-000070.Revenue: $70.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001425450-26-000070.Report this figure+1.5 pts on a year earlier
  • Diluted EPS−$0.30Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001425450-26-000070.Report this figure+0.0% on a year earlier
  • Free cash flow−$3.1mFree cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $928.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001425450-26-000070. Derived: 6-month figure less the 3-month figure.Capital expenditure: $4.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001425450-26-000070. Derived: 6-month figure less the 3-month figure.Report this figure+77.6% on a year earlier

Last eight quarters

Full statements
Revenue$70.5mGross margin 74.3%
Diluted EPS−$0.30, Q2 FY2026
Free cash flow−$3.1m, Q2 FY2026
Orthopediatrics Corp, key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$m54.6Revenue, Q3 FY2024, three months to 2024-09-30$54.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-29, accession 0001425450-25-000114.Report this figure52.7Revenue, Q4 FY2024, three months to 2024-12-31$52.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-04, accession 0001425450-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure52.4Revenue, Q1 FY2025, three months to 2025-03-31$52.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-01, accession 0001425450-26-000036.Report this figure61.1Revenue, Q2 FY2025, three months to 2025-06-30$61.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001425450-26-000070.Report this figure61.3Revenue, Q3 FY2025, three months to 2025-09-30$61.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-29, accession 0001425450-25-000114.Report this figure61.6Revenue, Q4 FY2025, three months to 2025-12-31$61.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-04, accession 0001425450-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure59.4Revenue, Q1 FY2026, three months to 2026-03-31$59.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-01, accession 0001425450-26-000036.Report this figure70.5Revenue, Q2 FY2026, three months to 2026-06-30$70.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001425450-26-000070.Report this figure
Gross margin%73.4%Gross margin, Q3 FY2024, three months to 2024-09-30. gross profit / revenueGross profit: $40.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-10-29, accession 0001425450-25-000114.Revenue: $54.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-29, accession 0001425450-25-000114.Report this figure67.5%Gross margin, Q4 FY2024, three months to 2024-12-31. gross profit / revenueGross profit: $35.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-04, accession 0001425450-26-000013. Derived: 12-month figure less the 9-month figure.Revenue: $52.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-04, accession 0001425450-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure73.0%Gross margin, Q1 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $38.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-01, accession 0001425450-26-000036.Revenue: $52.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-01, accession 0001425450-26-000036.Report this figure72.1%Gross margin, Q2 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $44.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-05, accession 0001425450-26-000070.Revenue: $61.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001425450-26-000070.Report this figure73.9%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $45.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-10-29, accession 0001425450-25-000114.Revenue: $61.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-29, accession 0001425450-25-000114.Report this figure73.2%Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: $45.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-04, accession 0001425450-26-000013. Derived: 12-month figure less the 9-month figure.Revenue: $61.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-04, accession 0001425450-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure73.1%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $43.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-01, accession 0001425450-26-000036.Revenue: $59.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-01, accession 0001425450-26-000036.Report this figure74.3%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $52.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-05, accession 0001425450-26-000070.Revenue: $70.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001425450-26-000070.Report this figure
Operating margin%(10.2%)Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: −$5.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-29, accession 0001425450-25-000114.Revenue: $54.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-29, accession 0001425450-25-000114.Report this figure(26.7%)Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: −$14.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-04, accession 0001425450-26-000013. Derived: 12-month figure less the 9-month figure.Revenue: $52.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-04, accession 0001425450-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure(21.0%)Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: −$11.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-01, accession 0001425450-26-000036.Revenue: $52.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-01, accession 0001425450-26-000036.Report this figure(17.4%)Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: −$10.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001425450-26-000070.Revenue: $61.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001425450-26-000070.Report this figure(15.4%)Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: −$9.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-29, accession 0001425450-25-000114.Revenue: $61.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-29, accession 0001425450-25-000114.Report this figure(13.3%)Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: −$8.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-04, accession 0001425450-26-000013. Derived: 12-month figure less the 9-month figure.Revenue: $61.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-04, accession 0001425450-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure(14.0%)Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: −$8.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-01, accession 0001425450-26-000036.Revenue: $59.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-01, accession 0001425450-26-000036.Report this figure(5.8%)Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$4.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001425450-26-000070.Revenue: $70.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001425450-26-000070.Report this figure
Net margin%(14.5%)Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: −$7.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-29, accession 0001425450-25-000114.Revenue: $54.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-29, accession 0001425450-25-000114.Report this figure(30.5%)Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: −$16.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-04, accession 0001425450-26-000013. Derived: 12-month figure less the 9-month figure.Revenue: $52.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-04, accession 0001425450-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure(20.3%)Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: −$10.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001425450-26-000070.Revenue: $52.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-01, accession 0001425450-26-000036.Report this figure(11.6%)Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: −$7.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001425450-26-000070.Revenue: $61.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001425450-26-000070.Report this figure(19.2%)Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: −$11.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-29, accession 0001425450-25-000114.Revenue: $61.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-29, accession 0001425450-25-000114.Report this figure(16.4%)Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: −$10.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-04, accession 0001425450-26-000013. Derived: 12-month figure less the 9-month figure.Revenue: $61.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-04, accession 0001425450-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure(18.0%)Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: −$10.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001425450-26-000070.Revenue: $59.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-01, accession 0001425450-26-000036.Report this figure(10.2%)Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$7.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001425450-26-000070.Revenue: $70.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001425450-26-000070.Report this figure
Diluted EPS$ per share(0.34)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-29, accession 0001425450-25-000114.Report this figurenot reported (Diluted EPS not reported)(0.46)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-01, accession 0001425450-26-000036.Report this figure(0.30)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001425450-26-000070.Report this figure(0.50)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.50 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-29, accession 0001425450-25-000114.Report this figurenot reported (Diluted EPS not reported)(0.45)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.45 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-01, accession 0001425450-26-000036.Report this figure(0.30)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001425450-26-000070.Report this figure
Free cash flow$m(11.7)Free cash flow, Q3 FY2024, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: −$10.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-29, accession 0001425450-25-000114. Derived: 9-month figure less the 6-month figure.Capital expenditure: $1.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-29, accession 0001425450-25-000114. Derived: 9-month figure less the 6-month figure.Report this figure(4.2)Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: −$4.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-04, accession 0001425450-26-000013. Derived: 12-month figure less the 9-month figure.Capital expenditure: −$262.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-04, accession 0001425450-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure(8.4)Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: −$4.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-01, accession 0001425450-26-000036.Capital expenditure: $4.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-01, accession 0001425450-26-000036.Report this figure(13.9)Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: −$10.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001425450-26-000070. Derived: 6-month figure less the 3-month figure.Capital expenditure: $3.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001425450-26-000070. Derived: 6-month figure less the 3-month figure.Report this figure(3.4)Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: −$581.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-29, accession 0001425450-25-000114. Derived: 9-month figure less the 6-month figure.Capital expenditure: $2.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-29, accession 0001425450-25-000114. Derived: 9-month figure less the 6-month figure.Report this figure9.7Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $10.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-04, accession 0001425450-26-000013. Derived: 12-month figure less the 9-month figure.Capital expenditure: $599.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-04, accession 0001425450-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure(5.0)Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: −$3.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-01, accession 0001425450-26-000036.Capital expenditure: $1.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-01, accession 0001425450-26-000036.Report this figure(3.1)Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $928.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001425450-26-000070. Derived: 6-month figure less the 3-month figure.Capital expenditure: $4.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001425450-26-000070. Derived: 6-month figure less the 3-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$236.3mGross margin 73.1%
Diluted EPS−$1.69, FY2025
Free cash flow−$16.0m, FY2025
Orthopediatrics Corp, key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m98.0Revenue, FY2021, twelve months to 2021-12-31$98.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-08, accession 0001425450-24-000013.Report this figure122Revenue, FY2022, twelve months to 2022-12-31$122.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-05, accession 0001425450-25-000015.Report this figure149Revenue, FY2023, twelve months to 2023-12-31$148.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-04, accession 0001425450-26-000013.Report this figure205Revenue, FY2024, twelve months to 2024-12-31$204.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-04, accession 0001425450-26-000013.Report this figure236Revenue, FY2025, twelve months to 2025-12-31$236.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-04, accession 0001425450-26-000013.Report this figure
Gross margin%74.9%Gross margin, FY2021, twelve months to 2021-12-31. gross profit / revenueGross profit: $73.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-03-08, accession 0001425450-24-000013.Revenue: $98.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-08, accession 0001425450-24-000013.Report this figure74.1%Gross margin, FY2022, twelve months to 2022-12-31. gross profit / revenueGross profit: $90.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-05, accession 0001425450-25-000015.Revenue: $122.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-05, accession 0001425450-25-000015.Report this figure74.8%Gross margin, FY2023, twelve months to 2023-12-31. gross profit / revenueGross profit: $111.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-04, accession 0001425450-26-000013.Revenue: $148.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-04, accession 0001425450-26-000013.Report this figure72.6%Gross margin, FY2024, twelve months to 2024-12-31. gross profit / revenueGross profit: $148.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-04, accession 0001425450-26-000013.Revenue: $204.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-04, accession 0001425450-26-000013.Report this figure73.1%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $172.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-04, accession 0001425450-26-000013.Revenue: $236.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-04, accession 0001425450-26-000013.Report this figure
Operating margin%(18.4%)Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: −$18.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-03-08, accession 0001425450-24-000013.Revenue: $98.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-08, accession 0001425450-24-000013.Report this figure(20.8%)Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: −$25.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-05, accession 0001425450-25-000015.Revenue: $122.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-05, accession 0001425450-25-000015.Report this figure(18.0%)Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: −$26.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-04, accession 0001425450-26-000013.Revenue: $148.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-04, accession 0001425450-26-000013.Report this figure(17.1%)Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: −$35.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-04, accession 0001425450-26-000013.Revenue: $204.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-04, accession 0001425450-26-000013.Report this figure(16.6%)Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: −$39.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-04, accession 0001425450-26-000013.Revenue: $236.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-04, accession 0001425450-26-000013.Report this figure
Net margin%(16.6%)Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: −$16.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-03-08, accession 0001425450-24-000013.Revenue: $98.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-08, accession 0001425450-24-000013.Report this figure1.0%Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: $1.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-05, accession 0001425450-25-000015.Revenue: $122.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-05, accession 0001425450-25-000015.Report this figure(14.1%)Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: −$21.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-04, accession 0001425450-26-000013.Revenue: $148.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-04, accession 0001425450-26-000013.Report this figure(18.5%)Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: −$37.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-04, accession 0001425450-26-000013.Revenue: $204.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-04, accession 0001425450-26-000013.Report this figure(16.8%)Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: −$39.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-04, accession 0001425450-26-000013.Revenue: $236.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-04, accession 0001425450-26-000013.Report this figure
Diluted EPS$ per share(0.84)Diluted EPS, FY2021, twelve months to 2021-12-31−$0.84 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-03-08, accession 0001425450-24-000013.Report this figure0.06Diluted EPS, FY2022, twelve months to 2022-12-31$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-03-05, accession 0001425450-25-000015.Report this figure(0.92)Diluted EPS, FY2023, twelve months to 2023-12-31−$0.92 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-04, accession 0001425450-26-000013.Report this figure(1.64)Diluted EPS, FY2024, twelve months to 2024-12-31−$1.64 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-04, accession 0001425450-26-000013.Report this figure(1.69)Diluted EPS, FY2025, twelve months to 2025-12-31−$1.69 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-04, accession 0001425450-26-000013.Report this figure
Free cash flow$m(21.2)Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: −$13.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-03-08, accession 0001425450-24-000013.Capital expenditure: $8.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-03-08, accession 0001425450-24-000013.Report this figure(31.8)Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: −$21.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-05, accession 0001425450-25-000015.Capital expenditure: $10.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-05, accession 0001425450-25-000015.Report this figure(43.9)Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: −$27.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-04, accession 0001425450-26-000013.Capital expenditure: $16.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-04, accession 0001425450-26-000013.Report this figure(41.3)Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: −$27.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-04, accession 0001425450-26-000013.Capital expenditure: $14.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-04, accession 0001425450-26-000013.Report this figure(16.0)Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: −$4.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-04, accession 0001425450-26-000013.Capital expenditure: $11.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-04, accession 0001425450-26-000013.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Orthopediatrics Corp
FundQuarter endedReported valueSharesPut or callChange on the quarter before
BROWN ADVISORY INC2026-06-30$32.1m1,678,983Added+160,965
BlackRock, Inc.2026-06-30$24.3m1,272,714Added+98,668
BRAIDWELL LP2026-06-30$21.1m1,100,370Unchanged
Granahan Investment Management, LLC2026-06-30$20.8m1,085,964Added+189,223
MILLENNIUM MANAGEMENT LLC2026-06-30$15.6m816,830Reduced−420,069
WELLINGTON MANAGEMENT GROUP LLP2026-06-30$15.2m794,309Reduced−93,135
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$14.5m755,624Added+37,448
Soleus Capital Management, L.P.2026-06-30$14.0m732,144Added+116,697
MORGAN STANLEY2026-06-30$13.3m693,387Reduced−447,731
WASATCH ADVISORS LP2026-06-30$9.9m515,677Added+186,357

Recent filings

All 623 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Orthopediatrics Corp, recent filings
FiledFormWhat it isAccession number
2026-10-2716:15 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001425450-26-000092
2026-10-2716:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001425450-26-000091
2026-09-1108:44 ETSCHEDULE 13D/AOwnership report, active investor, amended0001193125-26-388676
2026-09-0118:40 ETSCHEDULE 13D/AOwnership report, active investor, amended0001193125-26-378878
2026-08-0513:56 ET10-QQuarterly reportPeriod 2026-06-300001425450-26-000070
2026-08-0416:31 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001425450-26-000067
2026-08-0416:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001425450-26-000066
2026-06-0416:22 ET8-K5.07 Shareholder vote results0001425450-26-000041
2026-05-0115:45 ET10-QQuarterly reportPeriod 2026-03-310001425450-26-000036
2026-04-3016:12 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001425450-26-000033

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Mar 4, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested.See the target

About the filer

CIK
1425450
Tickers
KIDS
Exchange
Nasdaq
SIC code
3841 Surgical & Medical Instruments & Apparatus
Sector
Healthcare
Fiscal year ends
Dec 31
Incorporated in
not reported
Filer category
Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 16:17 ET. Listed shows no prices and gives no investment advice.